1. Home
  2. TOVX vs AYRO Comparison

TOVX vs AYRO Comparison

Compare TOVX & AYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • AYRO
  • Stock Information
  • Founded
  • TOVX 2001
  • AYRO 2017
  • Country
  • TOVX United States
  • AYRO United States
  • Employees
  • TOVX N/A
  • AYRO N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • AYRO Telecommunications Equipment
  • Sector
  • TOVX Health Care
  • AYRO Consumer Discretionary
  • Exchange
  • TOVX Nasdaq
  • AYRO Nasdaq
  • Market Cap
  • TOVX 4.0M
  • AYRO 4.1M
  • IPO Year
  • TOVX 2006
  • AYRO N/A
  • Fundamental
  • Price
  • TOVX $1.41
  • AYRO $0.52
  • Analyst Decision
  • TOVX Strong Buy
  • AYRO
  • Analyst Count
  • TOVX 1
  • AYRO 0
  • Target Price
  • TOVX $6.00
  • AYRO N/A
  • AVG Volume (30 Days)
  • TOVX 21.6K
  • AYRO 144.1K
  • Earning Date
  • TOVX 05-06-2025
  • AYRO 05-14-2025
  • Dividend Yield
  • TOVX N/A
  • AYRO N/A
  • EPS Growth
  • TOVX N/A
  • AYRO N/A
  • EPS
  • TOVX N/A
  • AYRO N/A
  • Revenue
  • TOVX N/A
  • AYRO $63,777.00
  • Revenue This Year
  • TOVX N/A
  • AYRO N/A
  • Revenue Next Year
  • TOVX N/A
  • AYRO N/A
  • P/E Ratio
  • TOVX N/A
  • AYRO N/A
  • Revenue Growth
  • TOVX N/A
  • AYRO N/A
  • 52 Week Low
  • TOVX $0.96
  • AYRO $0.38
  • 52 Week High
  • TOVX $12.25
  • AYRO $1.48
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 58.99
  • AYRO 50.87
  • Support Level
  • TOVX $1.28
  • AYRO $0.48
  • Resistance Level
  • TOVX $1.47
  • AYRO $0.57
  • Average True Range (ATR)
  • TOVX 0.13
  • AYRO 0.06
  • MACD
  • TOVX 0.03
  • AYRO 0.01
  • Stochastic Oscillator
  • TOVX 87.13
  • AYRO 72.63

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About AYRO AYRO Inc.

AYRO Inc designs and manufactures compact, sustainable electric vehicles for closed campus mobility, low-speed urban and community transport, local on-demand and last-mile delivery, and government use. It operates as one reportable segment, focusing on the manufacturing and sales of environmentally-conscious, minimal-footprint EVs.

Share on Social Networks: